SUDARSHAN PHARMA IND LTD Share Price

₹ 35.50

-₹0.92 (-2.53%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: SUDARSHAN
|
Pharmaceuticals

SUDARSHAN PHARMA IND LTD Share Price Today

As of 3 Nov 2026, SUDARSHAN PHARMA IND LTD share price is ₹35.50. The stock opened at ₹37.55, compared to its previous close of ₹36.42. During today's trading session, SUDARSHAN PHARMA IND LTD share price moved in the range of ₹34.60 to ₹37.99, with an average price of ₹36.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹32.10 and a high of ₹39.30. On the performance front, SUDARSHAN PHARMA IND LTD share price has increased by 1.44% over the last six months and is up 1.44% on a year-on-year basis.

Share price over the last 1 day fell from 37.51 to 35.50, ranging between 34.60 and 37.51.
₹34.60
2.53% down today
₹37.99
1D LOW
1D HIGH

SUDARSHAN PHARMA IND LTD Stock Insights

Latest Earning
Op Profit TrendUp by 43.81% QoQ
Latest Earning
Net Profit TrendUp by 38.68% QoQ
Latest Earning
Revenue TrendUp by 24.63% QoQ
Stock Performance
OutperformingBeat Nifty by 3.17 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 1.89%
Shareholding Pattern
FIIFII increased stake by 10.44%
SUDARSHAN PHARMA IND LTD stock performance
Open₹37.55
High₹37.99
Low₹34.60
Prev. close₹36.42
SUDARSHAN PHARMA IND LTD trading activity
Volume1,14,083
Average traded price₹35.55
Last traded time03:29:20 02 Nov
Last traded quantity1
Circuit
L
H
₹31.65
₹38.67
52-week
L
H
₹32.10
₹39.30
Mkt Cap Cr
912.02
P/E
31.44
P/B
4.67
ROA
3.8%
ROE
14.85%
ROCE
12.17%
Quick Ratio
0.6
EV/EBITDA
17.26

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Sudarshan Pharma outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Sudarshan Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Sudarshan Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Pidilite Industries1,51,253.2254.7213.2616.75%23.94%31.93%1.936.42
SRF69,481.9831.164.658.83%14.92%14.86%0.6818.48
Linde India48,171.6988.1611.299.41%12.87%17.16%0.7648.78
Gujarat Fluorochemicals46,693.9477.825.975.05%7.13%8.93%0.9735.15
Navin Fluorine43,104.2748.899.9813.33%20.41%22.03%2.1931.05
Godrej Industries30,491.7613.82.731.75%11.1%9.34%0.3512.06
Himadri Speciality Chemicals26,255.5229.935.0112.32%16.65%19.3%1.6720.28
Aether Industries21,507.9686.298.296.92%9.61%10.65%0.9651.82
Deepak Nitrite20,724.9219.513.210.83%16.4%18.59%1.7312.55
Castrol India18,595.5018.7510.0646.22%46.94%71.77%1.2812.07

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SUDARSHAN PHARMA IND LTD Company Background

ISIN
INE00TV01023
Sector Market Cap
₹ 912.02 Cr

Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.

SUDARSHAN PHARMA IND LTD Financial Highlights

  • Revenue: SUDARSHAN PHARMA IND LTD reported revenue of ₹711.77 crore in FY26 vs ₹507.70 crore in FY25. It showed an increase of 40.19% on a yearly basis.
  • Operating Profit: SUDARSHAN PHARMA IND LTD reported an operating profit of ₹30.54 crore in FY26 vs ₹20.02 crore in FY25. It showed an increase of 52.55% on a year-on-year basis.
  • Net Profit: SUDARSHAN PHARMA IND LTD reported a net profit of ₹23.37 crore in FY26 vs ₹14.97 crore in FY25. It showed an increase of 56.11% on a yearly basis.

SUDARSHAN PHARMA IND LTD Quarterly Result Highlights

  • SUDARSHAN PHARMA IND LTD reported revenue of ₹218.90 crore in Sep 2026, compared with ₹175.64 crore in Jun 2026, representing an increase of 24.63% on a quarter-on-quarter (QoQ) basis.
  • SUDARSHAN PHARMA IND LTD reported an operating profit of ₹10.80 crore in Sep 2026, compared with ₹7.51 crore in Jun 2026, representing an increase of 43.81% on a quarter-on-quarter (QoQ) basis.
  • SUDARSHAN PHARMA IND LTD reported a profit of ₹7.78 crore in Sep 2026, compared with ₹5.61 crore in Jun 2026, reflecting an increase of 38.68% on a QoQ basis.
  • The earnings per share (EPS) of SUDARSHAN PHARMA IND LTD stood at ₹0.97 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
57.81%
FII
21.95%
Other DII
0.00%
Retail and other
20.24%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 202619.95%
Jun 202619.38%
Aug 202619.87%
Sep 202621.95%

SUDARSHAN PHARMA IND LTD Investment Returns

1 day
-3.46%
1 week
+1.44%
1 month
+1.44%
1 year
+1.44%
3 years
+1.44%
5 years
+1.44%

SUDARSHAN PHARMA IND LTD Share Price History

SUDARSHAN PHARMA IND LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹37.55 / ₹35.16
-3.46%
30 Oct 26
₹39.04 / ₹36.42
-2.83%
29 Oct 26
₹37.99 / ₹37.48
-1.16%
28 Oct 26
₹34.99 / ₹37.92
+9.41%
Show more

SUDARSHAN PHARMA IND LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹703.06₹505.05₹463.54₹461.33
Other Income₹8.71₹2.52₹2.61₹1.12
Total Revenue₹711.77₹507.57₹466.15₹462.45
Total Expenses₹681.23₹483.12₹450.92₹452.95
Profit Before Tax₹30.54₹21.63₹15.23₹9.50
Tax₹7.17₹5.68₹3.77₹2.46
Profit After Tax₹23.37₹15.95₹11.46₹7.04
EPS - Basic₹0.97₹0.66₹4.76₹5.48
EPS - Diluted₹0.97₹0.66₹4.76₹5.48

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹30.54₹20.02₹15.23₹9.50
Income before WC changes₹55.00₹37.09₹24.63₹15.32
Change in Assets-₹149.34-₹97.05-₹52.18-₹57.56
Change in Liabilities₹98.07₹30.57₹35.72₹15.56
Change in WC-₹51.27-₹66.48-₹16.46-₹42.00
Cash flow from Operations-₹2.30-₹32.32₹6.01-₹28.79
Cash flow from Investing-₹77.70-₹20.65-₹5.49-₹25.65
Cash flow from Financing₹79.17₹53.35-₹12.10₹65.93
Total Cash Flow-₹0.83₹0.37-₹11.58₹11.48
Cash (Start of the year)₹0.55₹0.14₹11.72₹0.24
Cash (End of the year)₹1.13₹0.55₹0.14₹11.72

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹151.48₹67.56₹41.55₹33.86
Current Assets₹490.26₹334.85₹241.57₹198.62
Total Assets₹641.75₹402.41₹283.13₹232.48
Current Liabilities₹456.12₹259.69₹160.82₹118.48
Net Current Asset₹34.15₹75.15₹80.75₹80.14
Non-Current Liabilities₹29.31₹11.23₹10.59₹13.03
Equity Capital₹156.32₹131.48₹111.71₹100.97
Total Equity & Liabilities₹641.75₹402.41₹283.13₹232.48

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹667.50₹502.49₹465.56₹461.33
Other Income₹8.40₹3.00₹2.75₹1.12
Total Revenue₹675.90₹505.49₹468.31₹462.45
Total Expenses₹647.23₹483.87₹453.22₹452.95
Profit Before Tax₹28.67₹18.81₹15.10₹9.50
Tax₹6.69₹4.78₹3.74₹2.46
Profit After Tax₹21.98₹14.02₹11.36₹7.04
EPS - Basic₹0.91₹0.58₹0.47₹5.48
EPS - Diluted₹0.90₹0.58₹0.47₹5.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹28.67₹18.81₹15.10₹9.50
Income before WC changes₹52.40₹40.96₹24.42₹15.32
Change in Assets-₹112.92-₹98.25-₹55.03-₹57.56
Change in Liabilities₹63.42₹26.95₹42.42₹15.56
Change in WC-₹49.50-₹71.30-₹12.62-₹42.00
Cash flow from Operations-₹2.75-₹33.18₹9.69-₹28.79
Cash flow from Investing-₹79.71-₹20.24-₹9.08-₹25.65
Cash flow from Financing₹82.18₹53.68-₹12.18₹65.93
Total Cash Flow-₹0.28₹0.26-₹11.58₹11.48
Cash (Start of the year)₹0.39₹0.13₹11.71₹0.23
Cash (End of the year)₹0.11₹0.39₹0.13₹11.71

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹149.43₹76.78₹43.99₹33.96
Current Assets₹444.75₹326.44₹240.85₹198.51
Total Assets₹594.18₹403.23₹284.84₹232.47
Current Liabilities₹410.05₹258.97₹162.27₹118.46
Net Current Asset₹34.70₹67.47₹78.58₹80.05
Non-Current Liabilities₹31.43₹13.55₹10.96₹13.03
Equity Capital₹152.71₹130.71₹111.62₹100.98
Total Equity & Liabilities₹594.18₹403.23₹284.84₹232.47
* All values are in INR Crore
SUDARSHAN PHARMA IND LTD market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
SUDARSHAN PHARMA IND LTD technical summary
Bearish indicators0
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
ATR (14)
3.53
Neutral
STOCH(9,6)
47.22
Neutral
ROC(12)
2.42
Bullish
WillR(14)
-52.78
Neutral
Period
Simple value
Exponential vaue
5D
36.4
0
10D
36.4
0
20D
36.4
0
50D
36.4
0
100D
36.4
0
Volume trend — traded volume by day
2 Nov1L
30 Oct1L
29 Oct1L
28 Oct1L
27 Oct0L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SUDARSHAN PHARMA IND LTD
Pharmaceuticals
Add Stock
Add Another

SUDARSHAN PHARMA IND LTD Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

SUDARSHAN PHARMA IND LTD Share Price FAQs

Please be aware that SUDARSHAN PHARMA IND LTD stock prices are subject to continuous fluctuations due to various factors.